Skip to content
ChickenStockChickenStock
ResearchCAI
Caris Life Sciences logo

Caris Life Sciences (CAI) stock

NASDAQ

$23.05-3.80%(-0.91)

As of the Nov 13, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

—

P/B

10.35x

P/S

6.94x

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 26.7% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 4, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

16 SEC filings
  • Denton John RusselSee Remarks · Sep 22, 2026Open-market sale7,500 shares · $239K
    Avg. price $31.8168174,855 shares held after
  • Brille Brian JSee Remarks · Sep 17, 2026Open-market sale400,000 shares · $12.1M
    Avg. price $30.3302230,303 shares held after
  • Brille Brian JSee Remarks · Sep 17, 2026Option exercise400,000 shares · $976K
    Avg. price $2.44630,303 shares held after
  • Spetzler David BaxleyPresident · Sep 4, 2026Open-market sale119,212 shares · $3.0M
    Avg. price $24.75521,182,871 shares held after
  • Spetzler David BaxleyPresident · Sep 4, 2026Option exercise250,000 shares · $610K
    Avg. price $2.441,302,083 shares held after
  • Spetzler David BaxleyPresident · Sep 3, 2026Open-market sale478,000 shares · $11.9M
    Avg. price $24.8598
    Show 2 price lots
    • 393,100 shares × $24.7604$9.7M
    • 84,900 shares × $25.3201$2.1M
  • Spetzler David BaxleyPresident · Sep 3, 2026Option exercise1,000,000 shares · $2.4M
    Avg. price $2.441,530,083 shares held after
  • Vacirca Jeff LDirector · Aug 14, 2026Grant or award13,192 shares · $0
    Avg. price $062,863 shares held after
  • JOHANSEN LAURA IDirector · Aug 14, 2026Grant or award13,192 shares · $0
    Avg. price $0343,897 shares held after
  • Fredrickson David PaulDirector · Aug 14, 2026Grant or award13,192 shares · $0
    Avg. price $031,813 shares held after
  • HALBERT JONDirector · Aug 14, 2026Grant or award13,192 shares · $0
    Avg. price $0131,813 shares held after
  • Minor LloydDirector · Aug 14, 2026Grant or award13,192 shares · $0
    Avg. price $031,813 shares held after
  • CASTLEMAN PETER MDirector · Aug 14, 2026Grant or award13,192 shares · $0
    Avg. price $029,321 shares held after
  • Gilliam Joseph EDirector · Aug 14, 2026Grant or award13,192 shares · $0
    Avg. price $029,321 shares held after
  • PHILLIPS T DANNYDirector · Aug 14, 2026Grant or award13,192 shares · $0
    Avg. price $0133,060 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Caris Life Sciences (CAI) stock information

NASDAQ

Caris Life Sciences (CAI) is listed on NASDAQ. Its market capitalization is about $6.6B. Return on equity is -0.9%. These figures are computed in-house from official filings and are reference information only.

Caris Life Sciences — frequently asked questions

What is the market capitalization of Caris Life Sciences?
CAI has a market capitalization of about $6.6B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.